Skip to main content
OpenTrials

Clinical trial condition

ADHD

Explore clinical trials studying ADHD. Study availability and eligibility vary by location and protocol.

395 public trials 57 recruiting studies
Refine in advanced search Browse all conditions

ADHD trial results

Completed

Treating Sleep in Teens With ADHD

NCT04270812

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +3 more
Locations
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT03618030

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Meridien Research Inc. Bradenton, Florida, United States
  • Meridien Research Lakeland, Florida, United States
  • Meridien Research Inc. Maitland, Florida, United States
  • South Shore Psychiatric Services Hingham, Massachusetts, United States
View Trial Details
Completed

KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD

NCT03460652

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Woodland International Research Little Rock, Arkansas, United States
  • MCB Clinical Research Centers Colorado Springs, Colorado, United States
  • Meridien Research Bradenton, Florida, United States
  • Clinical Neuroscience Solutions, Inc. Jacksonville, Florida, United States
View all 19 locations
View Trial Details
Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD

NCT03247543

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Alliance for Wellness Long Beach, California, United States
  • Innovative Clinical Research, Inc Lauderhill, Florida, United States
  • APG Research, LLC Orlando, Florida, United States
  • University of South Florida- Dept. of Psychiatry and Neurosciences Tampa, Florida, United States
View Trial Details
Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD

NCT03247530

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Indago Research & Health Center, Inc. Hialeah, Florida, United States
  • Advanced Clinical Research Meridian, Idaho, United States
  • Finger Lakes Clinical Research Rochester, New York, United States
View Trial Details
Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD

NCT03247556

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Alliance for Wellness dba Alliance for Research Long Beach, California, United States
  • MCB Clinical Research Centers, LLC Colorado Springs, Colorado, United States
  • Meridien Research at Florida Clinical Research Center Bradenton, Florida, United States
  • Innovative Clinical Research, Inc Lauderhill, Florida, United States
View all 14 locations
View Trial Details
Completed

KP415 Classroom Study in Children (6-12 Years of Age) With ADHD

NCT03292952

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Meridien Research Bradenton, Florida, United States
  • Meridien Research Maitland, Florida, United States
  • Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas, Nevada, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions